APOE and Alzheimer disease: This hypothesis is further supported by the increasing identification of genetic factors, including mitochondrial DNA haplogroups, apolipoprotein E, several key mitochondrial proteins, and many others that may have functional consequences of mitochondrial dysfunction as well as brain and systemic dysmetabolism in patients with AD (103–109).